Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Kavitha Gowrishankar
Based on 11 articles published since 2009
(Why 11 articles?)
||||
Expertise Level
The expertise of Kavitha Gowrishankar ranks in the
  • Top 1.2%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Aliases Gowrishankar, K   ·   Gowrishankar, Kavitha
Work Locations
Details
Most likely:    University of Sydney      
2015
  • Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, NSW, Australia. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia. · Melanoma Institute Australia, Crows Nest, Sydney, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, CA, USA. · Pubmed 26304929
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia. · Melanoma Institute of Australia, North Sydney, NSW, Australia. · Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom. · Pubmed 26087189
  • Melanoma Research, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 25844720
2014
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia; Melanoma Institute of Australia, North Sydney, New South Wales, Australia. Electronic address: · Pubmed 24906137
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
2012
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
2015
  • Kolling Medical Research Institute, Royal North Shore Hospital, University of Sydney, St Leonards, NSW 2065, Australia. · Pubmed 25572788
2014
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW, Australia. · Pubmed 24924589
2013
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
Probable:    Mater Hospital      
2015
  • Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, NSW, Australia. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia. · Melanoma Institute Australia, Crows Nest, Sydney, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, CA, USA. · Pubmed 26304929
2012
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
Probable:    Miscellaneous institutions in Sydney      
2015
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia. · Melanoma Institute of Australia, North Sydney, NSW, Australia. · Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom. · Pubmed 26087189
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Kavitha Gowrishankar about Melanoma:

  • Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma. 2015
  • Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. 2015
  • Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. 2015
  • Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB. 2015
  • Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. 2014
  • The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells. 2014
  • Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma. 2014
  • Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor. 2014
  • Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma. 2013
  • Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion. 2013
Show List of Full Article Records
Google Searches

Learn more about Kavitha Gowrishankar using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Sydney
Mater Hospital
Miscellaneous institutions in Sydney
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Sydney
2015
  • Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, NSW, Australia. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia. · Melanoma Institute Australia, Crows Nest, Sydney, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, CA, USA. · Pubmed 26304929
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia. · Melanoma Institute of Australia, North Sydney, NSW, Australia. · Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom. · Pubmed 26087189
  • Melanoma Research, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 25844720
2014
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales, Australia; Melanoma Institute of Australia, North Sydney, New South Wales, Australia. Electronic address: · Pubmed 24906137
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
2012
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
2015
  • Kolling Medical Research Institute, Royal North Shore Hospital, University of Sydney, St Leonards, NSW 2065, Australia. · Pubmed 25572788
2014
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW, Australia. · Pubmed 24924589
2013
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
Mater Hospital
2015
  • Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, NSW, Australia. · Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia. · Melanoma Institute Australia, Crows Nest, Sydney, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology, University of California Merced, Merced, CA, USA. · Pubmed 26304929
2012
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
Miscellaneous institutions in Sydney
2015
  • Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, St Leonards NSW, Australia. · Melanoma Institute of Australia, North Sydney, NSW, Australia. · Melanoma Immunology and Oncology Group, Centenary Institute, University of Sydney, Camperdown, NSW, Australia. · Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · School of Mathematics and Statistics, University of Sydney, Sydney NSW, Australia. · Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom. · Pubmed 26087189
Westmead Hospital
2014
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
2012
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
2013
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
Yearly article counts 00004421000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.